A detailed history of Bank Of America Corp transactions in Generation Bio Co. stock. As of the latest transaction made, Bank Of America Corp holds 2,981,448 shares of GBIO stock, worth $6.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,981,448
Previous 2,989,606 0.27%
Holding current value
$6.59 Million
Previous $12.2 Million 30.9%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.64 - $4.35 $21,537 - $35,487
-8,158 Reduced 0.27%
2,981,448 $8.41 Million
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $798,817 - $1.88 Million
461,744 Added 18.27%
2,989,606 $12.2 Million
Q4 2023

Feb 14, 2024

BUY
$0.91 - $3.35 $1.82 Million - $6.69 Million
1,997,419 Added 376.56%
2,527,862 $4.17 Million
Q2 2023

Aug 14, 2023

SELL
$3.5 - $5.67 $43,249 - $70,064
-12,357 Reduced 2.28%
530,443 $2.92 Million
Q1 2023

May 12, 2023

SELL
$3.61 - $7.01 $1.16 Million - $2.26 Million
-322,462 Reduced 37.27%
542,800 $2.33 Million
Q4 2022

Feb 10, 2023

BUY
$3.66 - $6.77 $947,222 - $1.75 Million
258,804 Added 42.67%
865,262 $3.4 Million
Q3 2022

Nov 14, 2022

BUY
$4.68 - $8.34 $2.74 Million - $4.88 Million
585,673 Added 2817.77%
606,458 $3.22 Million
Q2 2022

Aug 12, 2022

SELL
$4.87 - $9.41 $5,649 - $10,915
-1,160 Reduced 5.29%
20,785 $136,000
Q1 2022

May 16, 2022

SELL
$4.16 - $7.76 $608,608 - $1.14 Million
-146,300 Reduced 86.96%
21,945 $161,000
Q4 2021

Feb 08, 2022

BUY
$5.99 - $24.97 $811,950 - $3.38 Million
135,551 Added 414.61%
168,245 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $285,720 - $391,864
14,286 Added 77.61%
32,694 $819,000
Q2 2021

Sep 13, 2021

BUY
$24.34 - $38.34 $448,050 - $705,762
18,408 New
18,408 $496,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $130M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.